Table 7.
Genotypic | PCR Genes | Kappa Agreement | p-Value | ||
---|---|---|---|---|---|
Phenotypic | Negative (Susceptible) (n = 5) |
Positive (Resistant) (n = 52) |
|||
E-test | |||||
Susceptible (n = 21) | 4 (7%) | 17 (29.8%) | 0.193 | 0.036 ^ | |
Resistance (n = 36) | 1 (1.8%) | 35 (61.4%) | |||
mCIM (Meropenem) | |||||
Susceptible (n = 21) | 2 (3.5%) | 19 (33.3%) | 0.004 | 0.878 | |
Resistance (n = 36) | 3 (5.3%) | 33 (57.9%) | |||
mCIM (Imipenem) | |||||
Susceptible (n = 14) | 3 (5.3%) | 11 (19.3%) | 0.040 | 0.054 | |
Resistance (n = 43) | 2 (3.5%) | 41 (71.9%) | |||
Disc diffusion (Meropenem) | |||||
Susceptible (n = 3) | 2 (3.5%) | 1 (1.8%) | 0.465 | <0.001 ^ | |
Resistance (n = 54) | 3 (5.3%) | 51 (89.5%) | |||
Disc diffusion (Imipenem) | |||||
Susceptible (n = 11) | 4 (7%) | 7 (12.3%) | 0.431 | <0.001 ^ | |
Resistance (n = 46) | 1 (1.8%) | 45 (78.9%) |
^ significant p-value.